Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct
Status:
Not yet recruiting
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This trial aims to determine whether the addition of rosuvastatin to standard TB therapy in
pulmonary tuberculosis results in accelerated of sputum culture conversion. The trial will
also investigate potential new biomarkers of sterilising activity and immune-modulatory
activity.